DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
Clinical trials for DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS trials appear
Sign up with your email to follow new studies for DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune reset: CAR T-Cells take on lupus and other autoimmune diseases
Disease control OngoingThis early-phase study tests a one-time treatment called KYV-101, which uses a patient's own modified immune cells to target and destroy faulty B cells that drive autoimmune diseases like lupus, vasculitis, and scleroderma. Up to 24 adults will receive the therapy and be monitore…
Matched conditions: DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
Phase: PHASE1 • Sponsor: David Porter • Aim: Disease control
Last updated May 17, 2026 05:09 UTC
-
Immune cell therapy shows promise for Tough-to-Treat autoimmune diseases
Disease control OngoingThis early-stage study tests a new treatment called CNTY-101 for people with severe autoimmune diseases like lupus, scleroderma, and inflammatory myopathies that haven't responded to standard therapies. The treatment uses specially engineered immune cells to target and destroy fa…
Matched conditions: DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
Phase: PHASE1 • Sponsor: Century Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 05:07 UTC
-
New drug shows promise for scleroderma lung disease in early trial
Disease control OngoingThis study tests a new drug, tulisokibart, in 154 adults with systemic sclerosis (scleroderma) that has caused lung scarring (interstitial lung disease). The goal is to see if the drug can slow lung damage and improve breathing compared to a placebo. Participants must have had sc…
Matched conditions: DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS
Phase: PHASE2 • Sponsor: Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated May 13, 2026 15:59 UTC